Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Sudeep Pharma Limited (NSE: SUDEEPPHRM), ISIN INE0QPI01025 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
SUDEEPPHRM last traded at ₹1208.50 (+2.56%), with a 52-week range of ₹524.95 to ₹1376.00 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 76.15%, FIIs 2.93%, DIIs 14.06%, mutual funds 7.43%.
EquiSense Score (ECS): 85/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.